Syndax Pharmaceuticals, Inc.

NY · United States · Reporting entity ID 100001453597

Total reported 2019–2025

$13.2M

#422 of 2,960 reporting companies — 0% of all reported industry payments

$4.53M in general payments across 5,560 records, plus $8.64M in research funding across 695 records.

How it breaks down

General payments $4,530,046

Research funding $8,642,040

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.